drugset / Trial / NCT01959594
A Study To Observe Safety And Blood Concentrations Of PF-06412562 During And Following The Oral Administration Of Multiple Doses Of PF-06412562 In Healthy Adult Volunteers
RandomizedParallel-groupDouble-blindBasic science
Summary
This study is designed to evaluate the safety and plasma concentrations of PF-06412562 in healthy volunteers following three times daily oral dosing of PF-06412562 for 14 days
Timeline
- Start
- 2013-11
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-06412562 | Unknown | 3 mg | Oral |
| Subject | PF-06412562 | Unknown | 10 mg | Oral |
| Subject | PF-06412562 | Unknown | 25 mg | Oral |
Indications
No indication recorded.